Peking partnership for AZ

Pharmaceutical Executive Europe, October, 2007 by Anonymous

COMPANY NEWS

AstraZeneca plc (AZ; UK) has announced a strategic partnership with Peking University 3rd Hospital to open its first Clinical Pharmacology Unit (CPU) in China. The unit aims to enhance local clinical research capabilities and speed up access to new medicines to benefit Chinese patients.

The CPU will focus on Phase I clinical research, including clinical pharmacology and safety evaluations - steps necessary for launching new medicines in China, under the co-operative agreement, AZ will provide Peking University 3rd Hospital with personnel training, system audits and consulting services, and will also invest to upgrade facilities necessary for clinical research of medicines for infections, diabetes and cardiovascular diseases. The unit will accelerate access...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement